Perspective Therapeutics (FRA:AAJ0) OCF Margin %: 0.00% (As of Mar. 2026)


FRA:AAJ0 Perspective Therapeutics Inc FRA:AAJ0
31 GF Score
Price €2.56
! 1 Warning Sign
View Full Analysis

What is Perspective Therapeutics OCF Margin %?

Perspective Therapeutics FRA:AAJ0 +3.72% 31 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates FRA:AAJ0 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Perspective Therapeutics ranks worse than 122699.26% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Perspective Therapeutics's Cash Flow from Operations for the three months ended in Mar. 2026 was €-27.22 Mil. Perspective Therapeutics's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Perspective Therapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Perspective Therapeutics's current OCF Yield % is -27.00%.

The historical rank and industry rank for Perspective Therapeutics's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Perspective Therapeutics was -28.22%. The lowest was -119.97%. And the median was -71.42%.

FRA:AAJ0's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

Perspective Therapeutics OCF Margin % Related Terms

Perspective Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Perspective Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics OCF Margin % Chart

Perspective Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.22 -71.43 0.00 0.00 0.00

Perspective Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:AAJ0
31GF Score
Perspective Therapeutics Inc FRA:AAJ0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perspective Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Perspective Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-70.441/0
= %

Perspective Therapeutics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-27.22/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Perspective Therapeutics (FRA:AAJ0) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Perspective Therapeutics and its competitors. According to the industry distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Perspective Therapeutics' OCF Margin % too high?
Perspective Therapeutics' current OCF Margin % is 0.00%. Based on the distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Perspective Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Perspective Therapeutics' OCF Margin % compare to LAB and KIDS?
According to the Medical Devices & Instruments industry distribution chart, Perspective Therapeutics ranks #999999 out of 815 companies for OCF Margin %. This places Perspective Therapeutics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Perspective Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Perspective Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perspective Therapeutics stock overvalued right now?
Perspective Therapeutics (FRA:AAJ0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Perspective Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Perspective Therapeutics (FRA:AAJ0), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Perspective Therapeutics Business Description

Other Exchanges CATX:USA
Address 2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
31GF Score

Get the complete analysis for FRA:AAJ0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.56
Price